Guangzhou Yinming Biomedical Technology
PrivateLast Round
Series A
Extension
Sep 13, 2021
Total Funding Raised
$110M
Company Overview
MingMed is a biotechnology company specializing in the research and development of pharmaceutical drugs, including ophthalmic medications, small molecule immune therapies, and gene editing-based cell therapies for ophthalmology, medical aesthetics, and veterinary medicine.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Precision Medicine, Biotechnology, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangzhou Yinming Biomedical Technology Comps
Public and private peers based on sector, stage, and business model.
Guangzhou Yinming Biomedical Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 13, 2021 | ||||
| Series A | Mar 17, 2021 |
Guangzhou Yinming Biomedical Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JCP Capital | Series A |
| Oceanpine Capital | Series A Extension |
| Huajin Capital | Series A, Series A Extension |
| Lightspeed China Partners | Series A |
| Flower City Ventures | Series A, Series A Extension |
| Hengqin Financial Investment Group | Series A |
| Shenzhen Yifeng Investment Management Enterprise | Series A Extension |
Guangzhou Yinming Biomedical Technology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Guangzhou Yinming Biomedical Technology's valuation, stock price, and market status.